PR Newswire HONG KONG, Oct. 31, 2024 HONG KONG, Oct. 31, 2024 /PRNewswire/ -- Akeso Biopharma (9926.HK) is pleased to announce the successful enrollment of the first patient in the AK112-309 trial, a randomized, controlled, multicenter Phase ...
PR Newswire TOKYO and CAMBRIDGE, Mass., Oct. 31, 2024 TOKYO and CAMBRIDGE, Mass., Oct. 31, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
PR Newswire STOCKHOLM, Oct. 31, 2024 STOCKHOLM, Oct. 31, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed the rolling submission of a Biologics License Application ...
PR Newswire DUBLIN, Oct. 31, 2024 First presentation of top-line efficacy and safety results from the Phase 4 DUET (Develop hypersomnia Understanding by Evaluating low-sodium oxybate Treatment) trial of adults with narcolepsy or idiopathic ...
PR Newswire JERSEY CITY, N.J., Oct. 29, 2024 JERSEY CITY, N.J., Oct. 29, 2024 /PRNewswire/ -- Celltrion USA today announced a late-breaking post hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) of ZYMFENTRA® ...
PR Newswire SHANGHAI, Oct. 28, 2024 -- Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candidate (SCB-1019) -- -- RSV neutralizing antibodies for ...
Canada NewsWire TORONTO, Oct. 28, 2024 TORONTO, Oct. 28, 2024 /CNW/ - Sanofi is pleased to announce Beyfortus® (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this ...
PR Newswire FRANKFURT, Germany, Oct. 28, 2024 Lupin's R&D teams are working on products with a near-zero global warming potential propellant FRANKFURT, Germany, Oct. 28, 2024 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) ...
PR Newswire ROSEMONT, Ill., Oct. 28, 2024 Research published in the Journal of Oral and Maxillofacial Surgery (JOMS) reveals recreational marijuana users undergoing oral and maxillofacial surgery – such as tooth extractions or biopsies in an ...
PR Newswire EAST HANOVER, N.J., Oct. 26, 2024 EAST HANOVER, N.J., Oct. 26, 2024 /PRNewswire/ -- Novartis today presented 12-month data from the Phase III APPEAR-C3G study at American Society of Nephrology (ASN) Kidney Week 2024 showing that ...
Kerala government has initiated a statewide campaign across all 14 districts to address the issue of antibiotic overuse. ( ) This campaign is to confront antimicrobial resistance (AMR) which is one of the top global public health and ...
A glaucoma medication, methazolamide, has been found to reduce the accumulation of tau protein in zebrafish and mice, offering potential hope for treating neurodegenerative diseases like Alzheimer's ( ). Researchers in the UK Dementia Research ...
Link between nanoplastic pollution and antibiotic resistance has been identified. The research, published in Scientific Reports, shows that nanoplastic particles can hinder the effectiveness of antibiotics and potentially contribute to the ...
Australian research has found that the widespread use of the antibiotic rifaximin is fueling the rise of a nearly untreatable superbug. ( ) In a study published, international researchers led by the ...
Diabetes drug canagliflozin benefits patients of all ages. While Sodium-glucose cotransporter-2 (SGLT2) inhibitors are known to reduce the risk of heart and kidney problems in people with type 2 diabetes, this study confirms their effectiveness regardless of age. The findings will ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers